Position in COGT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$60,288,019
+$12,339,065 QoQ
Shares Held
1,557,830
+25.1% QoQ
Ownership
0.898%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 321 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,547,221 across 424 Biotechnology names. COGT ranks #29 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in COGT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,288,019 | 1,557,830 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $47,948,954 | 1,245,751 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $42,599,133 | 1,199,300 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $16,968,706 | 1,181,665 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,709,672 | 934,495 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,270,221 | 879,837 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,119,159 | 912,713 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $9,150,818 | 847,298 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,064,979 | 719,452 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,805,430 | 715,094 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,195,890 | 713,587 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,950,402 | 712,862 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,273,666 | 614,330 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,944,512 | 550,928 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,274,015 | 542,735 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,991,195 | 535,603 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,210,442 | 355,925 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,203,436 | 294,184 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,653,346 | 309,248 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,779,082 | 330,450 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,773,570 | 341,994 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $528,783 | 60,226 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $600,579 | 53,480 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||